Consistency batch to batch, and how many batches a year.
For cultivators
Flower on a UK stock list is a commodity. Flower with a market access partner is a brand.
The UK has no shortage of imported flower. What it lacks is producers with someone in the UK working their product into clinics and pharmacies every month. That is what this route gives you.
Your route in
Four steps, two agreements, one route.
1
Assessment
Certificates of analysis, GMP status, irradiation position, batch sizes and price position reviewed against UK requirements by our EU GMP manufacturing partner.
2
Release and distribution
Import, EU GMP release, UK packaging and distribution handled by the facility under its own licences, contracted direct with you.
3
Market access
We launch the product to UK clinics and dispensing pharmacies under a 12 month Market Access Agreement, contracted direct with you.
4
Repeat orders
Listings, prescriptions and reorders, with monthly market intelligence back to you on demand, pricing and gaps.
From the front line
What UK clinics and pharmacies actually ask about flower
Irradiated or non irradiated, and the microbial position behind it.
Terpene and cannabinoid profile data, presented compliantly to prescribers.
Price position against the products already on UK formularies.
Supply continuity. A product that goes out of stock loses its prescribers.
Does the route fit
Does the route fit your product?
EU GMP certified, or GACP with an EU GMP manufacturing partner.
Full certificates of analysis for every batch.
Capacity for a minimum 12 month supply programme.
Willing to commit to a 12 month UK market access programme.
A price position that works for UK private patients.
If you tick four of the five, register your interest.
Register your interest
Tell us about your product. We will tell you if the route fits.
We reply within two working days. Approved registrations receive access to the partner area with commercial terms and the agreement outline.